The ashwagandha paradox: a mixed-methods analysis of regulatory gaps, deceptive vendors and safety risks in the European online market
Applied Food Research · 2026-12 · 6 (2) · 102444
DOI: 10.1016/j.afres.2026.102444 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Applied Food Research, 2026-12. Verfasst von Bálint Márk Domián und 13 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Pécs Medical School.
Abstract (Originalsprache)
Ashwagandha ( Withania somnifera ) consumption is surging in Europe despite emerging pharmacovigilance reports linking it to hepatotoxicity. Regulatory oversight varies across the continent, ranging from unrestricted sale to strict bans, creating a fragmented landscape. This study investigated how these diverse regulatory frameworks impact online safety disclosures, product labelling compliance, and consumer exposure. We employed a sequential mixed-methods digital surveillance approach across three countries: Hungary (permissive), Poland (restricted limits), and Denmark (banned). First phase of the study involved search engine scraping of 150 websites and content analysis of health claims and safety warnings of 110 relevant identified sellers. Second phase involved test purchases of 12 samples to assess labelling compliance. A "regulatory paradox" was identified across the different jurisdictions. Polish webshops, operating under specific quantitative limits, demonstrated the highest general safety disclosure (n=37/43; 86.0% included warnings) in Phase I and labelling compliance (n=24/33; 72.7%) in Phase II. Meanwhile, fully legitimate vendors in Hungary provided limited warnings. In contrast, in Denmark resulted in a polarized market: while 54.84% of webshops (n=17/31) targeting Danish consumers provided zero safety warnings, unauthorized "rogue" pharmacy paradoxically provided more detailed clinical contraindication information than legal Hungarian vendors (p
Förderung
- University of Pécs Medical School
Zitieren
APA
Domián, B. M., Ashraf, A. R., Fittler, A. T., Pusztai, V., Horváth, Á. S., Sokoray-Varga, J., Fábián, E., Nagy, S. Á., Jónás, B., Kalocsa, L., Csupor-Löffler, B., Schmidt, J., Márk, L., & Vida, R. G. (2026). The ashwagandha paradox: a mixed-methods analysis of regulatory gaps, deceptive vendors and safety risks in the European online market. Applied Food Research, 6(2), 102444. https://doi.org/10.1016/j.afres.2026.102444
Vancouver
Domián BM, Ashraf AR, Fittler AT, Pusztai V, Horváth ÁS, Sokoray-Varga J, et al. The ashwagandha paradox: a mixed-methods analysis of regulatory gaps, deceptive vendors and safety risks in the European online market. Applied Food Research. 2026;6(2):102444. doi:10.1016/j.afres.2026.102444
BibTeX
@article{Domin2026,
author = {Domián, Bálint Márk and Ashraf, Amir Reza and Fittler, András Tamás and Pusztai, Viktória and Horváth, Áron Solt and Sokoray-Varga, Júlia and Fábián, Elvira and Nagy, Sándor Ádám and Jónás, Bence and Kalocsa, Luca and Csupor-Löffler, Boglárka and Schmidt, János and Márk, László and Vida, Róbert György},
title = {The ashwagandha paradox: a mixed-methods analysis of regulatory gaps, deceptive vendors and safety risks in the European online market},
journal = {Applied Food Research},
year = {2026},
volume = {6},
number = {2},
pages = {102444},
doi = {10.1016/j.afres.2026.102444}
}
EUVIMED